ResearcherGeorgia Institute of TechnologyNo recent work listed
Roman Mezencev
Matched on ORCID iD 0000-0003-4361-7628; OpenAlex author ID A5019750782.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 3 (first author 2, last author 0)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 2
2013: 1 paper · 2014: none · 2015: none · 2016: 2 papers
Papers 3
- Evidence for the role of microRNA 374b in acquired cisplatin resistance in pancreatic cancer cells. Co-author DOI 10.1038/cgt.2016.23↗
- Acquired resistance of pancreatic cancer cells to cisplatin is multifactorial with cell context-dependent involvement of resistance genes. First author DOI 10.1038/cgt.2016.71↗
- Molecular analysis of the inhibitory effect of N-acetyl-L-cysteine on the proliferation and invasiveness of pancreatic cancer cells. First author DOI 10.1097/cad.0b013e32836009d7↗
Closest collaborators
The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- John F. McDonald · 3 shared papers, 2013–2016
- Paper Evidence for the role of microRNA 374b in acquired cisplatin resistance in pancreatic cancer cells. DOI 10.1038/cgt.2016.23↗
- Paper Acquired resistance of pancreatic cancer cells to cisplatin is multifactorial with cell context-dependent involvement o… DOI 10.1038/cgt.2016.71↗
- Paper Molecular analysis of the inhibitory effect of N-acetyl-L-cysteine on the proliferation and invasiveness of pancreatic … DOI 10.1097/cad.0b013e32836009d7↗
- Roberto Schreiber · 1 shared paper, 2016
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.